Table 1.

Clinical description of patients at diagnosis

PatientLille score at diagnosisTime since diagnosis (y)Transfusion requirementsTherapy prior to blood samplingLeukocyte count (103/mL)Percentage of immature cells in the bloodHemoglobin level (g/dL)Platelet count (106/mL)Analysis in DDRT-PCRAnalysis in semiquantitative PCRAnalysis in quantitative PCRAnalysis in Western-blotAnalysis in flow cytometry
P1 Int No No 35 000 25 11.0 550  
P2 High 8.5 Yes HU + PU 74 100 39 9.9 82  
P3 Int Yes HU 21 000 15 7.7 92   
P4 Low No No 12 700 11.8 253  
P5 Low No HU 9 300 11.4 174   
P6 High No HU + PU 17 400 43 11.4 203  
P7 Low No HU 9 500 12.7 256     
P8 Int Yes HU 4 600 15 11.4 69     
P9 Int Yes HU 13 500 12 10.2 107     
P10 Low No HU 18 000 12.8 420     
PatientLille score at diagnosisTime since diagnosis (y)Transfusion requirementsTherapy prior to blood samplingLeukocyte count (103/mL)Percentage of immature cells in the bloodHemoglobin level (g/dL)Platelet count (106/mL)Analysis in DDRT-PCRAnalysis in semiquantitative PCRAnalysis in quantitative PCRAnalysis in Western-blotAnalysis in flow cytometry
P1 Int No No 35 000 25 11.0 550  
P2 High 8.5 Yes HU + PU 74 100 39 9.9 82  
P3 Int Yes HU 21 000 15 7.7 92   
P4 Low No No 12 700 11.8 253  
P5 Low No HU 9 300 11.4 174   
P6 High No HU + PU 17 400 43 11.4 203  
P7 Low No HU 9 500 12.7 256     
P8 Int Yes HU 4 600 15 11.4 69     
P9 Int Yes HU 13 500 12 10.2 107     
P10 Low No HU 18 000 12.8 420     

Presented are the clinical description of patients at diagnosis (Lille score19), time since diagnosis, transfusion requirement at the time of blood collection, therapy prior to blood collection, leukocyte count at the time of blood collection, and experiments performed with each sample.

HU indicates hydroxyurea; PU, 6-mercaptopurine.

Close Modal

or Create an Account

Close Modal
Close Modal